Gianluca Piatelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gianluca Piatelli has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Consales
Neurosurgery Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy
3 shared publications - Marco Pavanello
Neurosurgery Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
3 shared publications - Valeria Capra
Genomics and Clinical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy
3 shared publications - Andrea Accogli
Division of Medical Genetics, Department of Medicine, McGill University Health Center
2 shared publications - Armando Cama
U.O.C. Neurochirurgia, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy
2 shared publications - Claudia Milanaccio
Neuro-oncology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy
2 shared publications
Latest Publications
- Open Access
- 16 September 2025
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 30 (5) , 732-733
Cellular cannibalism in cytology: a distinctive feature of large cell/anaplastic medulloblastoma in a pediatric case
Not required for Clinical Vignette. Keywords: cellular cannibalism medulloblastoma pediatric
- 16 September 2025
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 30 (5) , 732-733
Open AccessCellular cannibalism in cytology: a distinctive feature of large cell/anaplastic medulloblastoma in a pediatric case
Not required for Clinical Vignette. Keywords: cellular cannibalism medulloblastoma pediatric
- Open Access
- 2 January 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (1) , 84-91
A Rare Pediatric Giant Cell Tumor of the Clivus Bone, H3.3 p.Gly35Trp-mutated: Case Report and Mini-review of the Literature
Introduction: Giant cell tumor of bone (GCTB) is a rare, typically benign neoplasm that primarily affects long bones in adults, with clival involvement being extremely rare, particularly in pediatric cases: a mini-review shows a total of 28 described cases, of which only 5 were truly pediatric (within 14 years of age). Surgery is the treatment of choice, and Denosumab is reported to be the most effective drug therapy. To date, the GCTB’s molecular hallmark is the somatic mutation p.Gly34Trp, at the H3F3A gene (H3.3 p.Gly34Trp mutation), but in this case, the mutation H3.3 p.Gly35Trp was identified. Case Presentation: A 9-year-old female presented with progressive ocular pain, ptosis, and diplopia. MRI revealed a 42 × 32 × 30 mm mass in the clivus and sphenoid body. The patient underwent partial resection, and histology confirmed GCTB. Molecular testing revealed the presence of the H3.3 p.Gly35Trp mutation, and we demonstrate that this is the true mutation associated with GCTB, not the previously described (H3.3 p.Gly34Trp). Due to residual tumor tissue, the patient was treated with Denosumab, a RANKL inhibitor. During a 2-year follow-up, the tumor size stabilized, and no significant adverse effects were observed. Conclusion: This case represents the first pediatric clival GCTB harboring the H3.3 p.Gly35Trp mutation. Molecular diagnostics played a crucial role in confirming the diagnosis and demonstrating that the true mutation harbored by GCTB is H3.3 p.Gly35Trp and not the formerly described (H3.3 p.Gly34Trp). Denosumab therapy effectively controlled the tumor without major side effects, although long-term treatment duration and safety require further study. Cite this article as: Gaggero G, Battaglia T, Andreotti V, et al. A rare pediatric giant cell tumor of the clivus bone, H3.3 p.Gly35Trp-mutated: case report and mini-review of the literature. Turk Arch Pediatr. 2025;60(1):84-91.
- 2 January 2025
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (1) , 84-91
Open AccessA Rare Pediatric Giant Cell Tumor of the Clivus Bone, H3.3 p.Gly35Trp-mutated: Case Report and Mini-review of the Literature
Introduction: Giant cell tumor of bone (GCTB) is a rare, typically benign neoplasm that primarily affects long bones in adults, with clival involvement being extremely rare, particularly in pediatric cases: a mini-review shows a total of 28 described cases, of which only 5 were truly pediatric (within 14 years of age). Surgery is the treatment of choice, and Denosumab is reported to be the most effective drug therapy. To date, the GCTB’s molecular hallmark is the somatic mutation p.Gly34Trp, at the H3F3A gene (H3.3 p.Gly34Trp mutation), but in this case, the mutation H3.3 p.Gly35Trp was identified. Case Presentation: A 9-year-old female presented with progressive ocular pain, ptosis, and diplopia. MRI revealed a 42 × 32 × 30 mm mass in the clivus and sphenoid body. The patient underwent partial resection, and histology confirmed GCTB. Molecular testing revealed the presence of the H3.3 p.Gly35Trp mutation, and we demonstrate that this is the true mutation associated with GCTB, not the previously described (H3.3 p.Gly34Trp). Due to residual tumor tissue, the patient was treated with Denosumab, a RANKL inhibitor. During a 2-year follow-up, the tumor size stabilized, and no significant adverse effects were observed. Conclusion: This case represents the first pediatric clival GCTB harboring the H3.3 p.Gly35Trp mutation. Molecular diagnostics played a crucial role in confirming the diagnosis and demonstrating that the true mutation harbored by GCTB is H3.3 p.Gly35Trp and not the formerly described (H3.3 p.Gly34Trp). Denosumab therapy effectively controlled the tumor without major side effects, although long-term treatment duration and safety require further study. Cite this article as: Gaggero G, Battaglia T, Andreotti V, et al. A rare pediatric giant cell tumor of the clivus bone, H3.3 p.Gly35Trp-mutated: case report and mini-review of the literature. Turk Arch Pediatr. 2025;60(1):84-91.
- 23 August 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 233, 107949
Calcification of the pump pouch in patients receiving ITB therapy: A rare complication affecting refill procedure – Analysis of two cases
- 23 August 2023
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 233, 107949
Calcification of the pump pouch in patients receiving ITB therapy: A rare complication affecting refill procedure – Analysis of two cases
- 18 February 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (3) , 646-652
Association of achondroplasia with sagittal synostosis and scaphocephaly in two patients, an underestimated condition?
We report on two patients with an unusual combination of achondroplasia and surgically treated sagittal synostosis and scaphocephaly. The most common achondroplasia mutation, p.Gly380Arg in fibroblast growth factor receptor 3 (FGFR3), was detected in both patients. Molecular genetic testing ofFGFR1,FGFR2,FGFR3andTWIST1genes failed to detect any additional mutations. There are several reports of achondroplasia with associated craniosynostosis, but no other cases of scaphocephaly in children with achondroplasia have been described. Recently it has been demonstrated thatFGFR3mutations affect not only endochondral ossification but also membranous ossification, providing new explanations for the craniofacial hallmarks in achondroplasia. Our report suggests that the association of isolated scaphocephaly and other craniosynostoses with achondroplasia may be under recognized.
- 18 February 2015
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 167 (3) , 646-652
Association of achondroplasia with sagittal synostosis and scaphocephaly in two patients, an underestimated condition?
We report on two patients with an unusual combination of achondroplasia and surgically treated sagittal synostosis and scaphocephaly. The most common achondroplasia mutation, p.Gly380Arg in fibroblast growth factor receptor 3 (FGFR3), was detected in both patients. Molecular genetic testing ofFGFR1,FGFR2,FGFR3andTWIST1genes failed to detect any additional mutations. There are several reports of achondroplasia with associated craniosynostosis, but no other cases of scaphocephaly in children with achondroplasia have been described. Recently it has been demonstrated thatFGFR3mutations affect not only endochondral ossification but also membranous ossification, providing new explanations for the craniofacial hallmarks in achondroplasia. Our report suggests that the association of isolated scaphocephaly and other craniosynostoses with achondroplasia may be under recognized.
- 19 June 2013
- Published by Springer Nature in Child's Nervous System
- Vol. 29 (10) , 1947-1952
Naso-ethmoidal encephalocele with bilateral orbital extension: report of a case in a western country
Encephalocele is a rare congenital malformation of the central nervous system with protrusion of cranial content (meninges, brain, and ventricles in different combinations) beyond the normal confines of the skull. Anterior encephaloceles occur with a high frequency in Southeast Asia, while in the Western countries occipital encephaloceles prevail. The treatment of an anterior (naso-ethmoidal) encephalocele involves a neurosurgeon or a multidisciplinary team (neurosurgeon, maxillofacial surgeon, plastic surgeon, and ENT surgeon) dealing with craniofacial surgery. Goals of surgery include removal or repositioning of nonfunctional cerebral tissue, closure of the dura, and reconstruction of skeletal and cutaneous structures. The prognosis depends from the anatomical site, volume of neural contents, and the presence of coexisting malformations. We report the case of an Italian child suffering from a naso-ethmoidal encephalocele with bilateral orbital extension. The surgical treatment was performed in two steps. Sincipital encephalocele is a complex pathology without a unique standardized surgical treatment. Its low incidence in Western countries can make its management particularly tricky.
- 19 June 2013
- Published by Springer Nature in Child's Nervous System
- Vol. 29 (10) , 1947-1952
Naso-ethmoidal encephalocele with bilateral orbital extension: report of a case in a western country
Encephalocele is a rare congenital malformation of the central nervous system with protrusion of cranial content (meninges, brain, and ventricles in different combinations) beyond the normal confines of the skull. Anterior encephaloceles occur with a high frequency in Southeast Asia, while in the Western countries occipital encephaloceles prevail. The treatment of an anterior (naso-ethmoidal) encephalocele involves a neurosurgeon or a multidisciplinary team (neurosurgeon, maxillofacial surgeon, plastic surgeon, and ENT surgeon) dealing with craniofacial surgery. Goals of surgery include removal or repositioning of nonfunctional cerebral tissue, closure of the dura, and reconstruction of skeletal and cutaneous structures. The prognosis depends from the anatomical site, volume of neural contents, and the presence of coexisting malformations. We report the case of an Italian child suffering from a naso-ethmoidal encephalocele with bilateral orbital extension. The surgical treatment was performed in two steps. Sincipital encephalocele is a complex pathology without a unique standardized surgical treatment. Its low incidence in Western countries can make its management particularly tricky.
- Open Access
- 15 August 2012
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 49 (3) , 582-588
Genetic Analysis of Disheveled 2 and Disheveled 3 in Human Neural Tube Defects
Neural tube defects are severe malformations affecting 1/1,000 live births. The planar cell polarity pathway controls the neural tube closure and has been implicated in the pathogenesis of neural tube defects both in animal models and human cohorts. In mouse disruption ofDvl2alone (Dvl2−/−) orDvl2andDvl3(Dvl2−/−;Dvl3+/−,Dvl2+/−;Dvl3−/−) results in incomplete neurulation, suggesting a role for Disheveled in neural tube closure. Disheveled is a multifunctional protein that is involved in both the canonical Wnt signaling and the noncanonical planar cell polarity pathway. In this study, we analyzed the role of the human orthologsDVL2andDVL3in a cohort of 473 patients with neural tube defects. Rare variants were genotyped in 639 ethnically matched controls. We identified seven rare missense mutations that were absent in all controls analyzed. Two of these mutations, p.Tyr667Cys and p.Ala53Val, identified inDVL2were predicted to be detrimental in silico. Significantly, a 1-bp insertion (c.1801_1802insG) in exon 15 ofDVL2predicted to lead to the truncation of the protein was identified in a patient with a complex form of caudal agenesis. In summary, we demonstrate a possible role for rare variants inDVL2gene as risk factors for neural tube defects.
- 15 August 2012
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 49 (3) , 582-588
Open AccessGenetic Analysis of Disheveled 2 and Disheveled 3 in Human Neural Tube Defects
Neural tube defects are severe malformations affecting 1/1,000 live births. The planar cell polarity pathway controls the neural tube closure and has been implicated in the pathogenesis of neural tube defects both in animal models and human cohorts. In mouse disruption ofDvl2alone (Dvl2−/−) orDvl2andDvl3(Dvl2−/−;Dvl3+/−,Dvl2+/−;Dvl3−/−) results in incomplete neurulation, suggesting a role for Disheveled in neural tube closure. Disheveled is a multifunctional protein that is involved in both the canonical Wnt signaling and the noncanonical planar cell polarity pathway. In this study, we analyzed the role of the human orthologsDVL2andDVL3in a cohort of 473 patients with neural tube defects. Rare variants were genotyped in 639 ethnically matched controls. We identified seven rare missense mutations that were absent in all controls analyzed. Two of these mutations, p.Tyr667Cys and p.Ala53Val, identified inDVL2were predicted to be detrimental in silico. Significantly, a 1-bp insertion (c.1801_1802insG) in exon 15 ofDVL2predicted to lead to the truncation of the protein was identified in a patient with a complex form of caudal agenesis. In summary, we demonstrate a possible role for rare variants inDVL2gene as risk factors for neural tube defects.